Pharmacogenomic-guided drug development: regulatory perspective

Publisher Website

1 January 2002

journal article
Published by Springer Nature in The Pharmacogenomics Journal

Vol. 2 (1) , 20-24
https://doi.org/10.1038/sj.tpj.6500046

Abstract

No abstract available

Keywords

This publication has 4 references indexed in Scilit:

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
The Lancet, 2000
The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis
New England Journal of Medicine, 1998